Page last updated: 2024-10-24

celecoxib and Abdominal Migraine

celecoxib has been researched along with Abdominal Migraine in 7 studies

Research Excerpts

ExcerptRelevanceReference
"9% (25/282) of placebo-treated subjects reported a treatment-emergent adverse event (TEAE)."2.94Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study. ( Brand-Schieber, E; Dodick, DW; Lipton, RB; Munjal, S; Tepper, SJ, 2020)
"Migraine is a common disabling condition that results in considerable socioeconomic loss."2.73Randomised, open label, controlled trial of celecoxib in the treatment of acute migraine. ( Loo, CY; Raymond, AA; Tan, HJ; Teh, HS, 2007)
"We present the first successful migraine headache treatment with therapy specifically targeting HSV infection."1.48Migraine Headache Treated with Famciclovir and Celecoxib: A Case Report. ( Morimoto, M; Napier, BL; Napier, E, 2018)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Woods, RH1
Lipton, RB1
Munjal, S1
Brand-Schieber, E1
Tepper, SJ1
Dodick, DW1
Schain, AJ1
Melo-Carrillo, A1
Ashina, S1
Strassman, AM1
Burstein, R1
Napier, BL1
Morimoto, M1
Napier, E1
Peres, MF1
Silberstein, SD1
Loo, CY1
Tan, HJ1
Teh, HS1
Raymond, AA1
Mathew, NT1
Kailasam, J1
Fischer, A1

Trials

2 trials available for celecoxib and Abdominal Migraine

ArticleYear
Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
    Headache, 2020, Volume: 60, Issue:1

    Topics: Acute Disease; Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Humans; M

2020
Randomised, open label, controlled trial of celecoxib in the treatment of acute migraine.
    Singapore medical journal, 2007, Volume: 48, Issue:9

    Topics: Acute Disease; Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Humans; Male; Migraine Disorde

2007

Other Studies

5 other studies available for celecoxib and Abdominal Migraine

ArticleYear
Alopecia signals associated with calcitonin gene-related peptide inhibitors in the treatment or prophylaxis of migraine: A pharmacovigilance study.
    Pharmacotherapy, 2022, Volume: 42, Issue:10

    Topics: Alopecia; Anticonvulsants; Biological Products; Botulinum Toxins, Type A; Calcitonin Gene-Related Pe

2022
Celecoxib reduces cortical spreading depression-induced macrophage activation and dilatation of dural but not pial arteries in rodents: implications for mechanism of action in terminating migraine attacks.
    Pain, 2020, Volume: 161, Issue:5

    Topics: Animals; Arteries; Celecoxib; Cortical Spreading Depression; Dilatation; Female; Macrophage Activati

2020
Migraine Headache Treated with Famciclovir and Celecoxib: A Case Report.
    The Permanente journal, 2018, Volume: 22

    Topics: 2-Aminopurine; Antiviral Agents; Celecoxib; Cyclooxygenase 2 Inhibitors; Famciclovir; Female; Herpes

2018
Hemicrania continua responds to cyclooxygenase-2 inhibitors.
    Headache, 2002, Volume: 42, Issue:6

    Topics: Celecoxib; Cyclooxygenase Inhibitors; Female; Humans; Indomethacin; Lactones; Male; Migraine Disorde

2002
Responsiveness to celecoxib in chronic paroxysmal hemicrania.
    Neurology, 2000, Jul-25, Volume: 55, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Female; Humans; Migraine Disorders; Pyraz

2000